Host and Bacterial Urine Proteomics Might Predict Treatment Outcomes for Immunotherapy in Advanced NSCLC

ABSTRACT: Urine extracellular vesicles from NSCLC patients were analyzed via LC-MS/MS to identify host and microbial proteins associated with progression-free survival. The study included 33 baseline urine samples and follow-up data. Samples were processed using EVtrap and analyzed on a Q-Exactive HF-X using a 60-minute gradient.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Urine

DISEASE(S): Non-small Cell Lung Carcinoma

SUBMITTER: David Dora  

LAB HEAD: Dr. David Dora

PROVIDER: PXD062630 | Pride | 2025-04-10

REPOSITORIES: Pride